Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

Forest Labs Says FDA Approves Depression Drug

By Pharmaceutical Processing | July 26, 2013

Forest Laboratories said Friday that the Food and Drug Administration has approved its depression drug Fetzima, and the drug should be available in the fourth quarter.

Forest makes Alzheimer’s treatment Namenda and another antidepressant, Lexapro, whose sales have shrunk because of generic competition. The New York company has had a handful of new drugs approved in the last couple years.

Forest said Fetzima, or levomilnacipran, was approved as a treatment for major depressive disorder in adults. It’s a pill intended to be taken once per day.

The drug is a serotonin and norepinephrine reuptake inhibitor, or SNRI. SNRIs are commonly used to treat depression and anxiety. Eli Lilly and Co. makes an SNRI called Cymbalta, while Pfizer Inc.’s are Effexor and Pristiq.

Shares of Forest rose 42 cents to $44.41 Friday and lost 39 cents to $44.11 in aftermarket trading.

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE